Aniridia, PAX6, and Beyond…

Eye Development and Disease

UVA Ophthalmology is sponsoring a conference on congenital eye disease.  At this conference there will be leading researchers focusing on new insights into how the eye and vision are established during development, and how congenital eye disease caused by mutation in these genes can be studied and potentially treated using the targeted gene technologies of precision medicine.  There will be opportunities for students and post-docs to present posters or short talks.

2019 Congenital Eye Disease Conference

Aniridia, PAX6, and Beyond… Eye Development and Disease

Date: November 1 – 3, 2019
Location: University of Virginia, Charlottesville, VA

For further information about this conference, please email RMG9P@virginia.edu.

As we get closer to the date, we will post more information and registration details.

Speakers include:

  • Ruth Ashery-Padan, Tel Aviv University
  • Brian Brooks, National Institutes of Health, National Eye Institute
  • Seth Blackshaw, Johns Hopkins University
  • Dominique Bremond-Gignac, Université Paris V Descartes, Hôpital Universitaire Necker
  • Alex Cvekl, Albert Einstein College of Medicine
  • Melinda Duncan, University of Delaware
  • David Fitzpatrick, University of Edinburgh, MRC Institute of Genetics and Molecular Medicine
  • Tom Glaser, University of California, Davis
  • Robert Grainger, University of Virginia
  • Cheryl Gregory-Evans, University of British Columbia, Eye Care Centre
  • Kevin Gregory-Evans, University of British Columbia, Eye Care Centre
  • Zbynek Kozmik, Academy of Sciences of the Czech Republic
  • James Lauderdale, University of Georgia
  • Neil Lagali, Linköping University
  • Xiaorong Liu, University of Virginia
  • Peter Netland, University of Virginia
  • Quintus Nguma, PTC Therapeutics
  • Elena Semina, Medical College of Wisconsin
  • Veronica van Heyningen, University College, London
  • Marla Weetall, PTC Therapeutics